Real-time Taqman PCR targeting 14 human papilloma virus types

Journal of Clinical Virology

Volumn 40, Issue 4, 2007, Pages 321-324

  Lindh, Magnus ^a   Görander, Staffan ^a   Andersson, Elin ^a   Horal, Peter ^a   Mattsby Balzer, Inger ^a   Ryd, Walter ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cervical dysplasia; Co infection; HPV subtype; Linear Array

Indexed keywords

ARTICLE; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS LOAD; VIRUS TYPING; WART VIRUS;

FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS; VIRAL LOAD;

EID: 36348962395     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.09.009     Document Type: Article

References (14)

1. Cuschieri K.S., Cubie H.A., Whitley M.W., Seagar A.L., Arends M.J., Moore C., et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 57 (2004) 68-72
2. Fife K.H., Cramer H.M., Schroeder J.M., and Brown D.R. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 64 (2001) 550-559
3. Flores-Munguia R., Siegel E., Klimecki W.T., and Giuliano A.R. Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types. J Mol Diagn 6 (2004) 115-124
4. Han J., Swan D.C., Smith S.J., Lum S.H., Sefers S.E., Unger E.R., et al. Simultaneous amplification and identification of 25 human papillomavirus types with templex technology. J Clin Microbiol 44 (2006) 4157-4162
5. Hart K.W., Williams O.M., Thelwell N., Fiander A.N., Brown T., Borysiewicz L.K., et al. Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples. J Clin Microbiol 39 (2001) 3204-3212
6. Meijer C.J., Snijders P.J., and Castle P.E. Clinical utility of HPV genotyping. Gynecol Oncol 103 (2006) 12-17
7. Moberg M., Gustavsson I., and Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 41 (2003) 3221-3228
8. Moberg M., Gustavsson I., and Gyllensten U. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer 112 (2004) 854-859
9. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
10. Roden R., and Wu T.C. How will HPV vaccines affect cervical cancer?. Nat Rev Cancer 6 (2006) 753-763
11. Rousseau M.C., Villa L.L., Costa M.C., Abrahamowicz M., Rohan T.E., and Franco E. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Transm Dis 30 (2003) 581-587
12. Sasagawa T., Basha W., Yamazaki H., and Inoue M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 10 (2001) 45-52
13. Terry G., Ho L., Londesborough P., Cuzick J., Mielzynska-Lohnas I., and Lorincz A. Detection of high-risk HPV types by the hybrid capture 2 test. J Med Virol 65 (2001) 155-162
14. van Ham M.A., Bakkers J.M., Harbers G.K., Quint W.G., Massuger L.F., and Melchers W.J. Comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol 43 (2005) 2662-2667